1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Dordaviprone (ONC201): new trials by email Literature Review of Dordaviprone (ONC201) trials Research Report on Dordaviprone (ONC201)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Dordaviprone (ONC201), Dordaviprone (ONC201) + Placebo, Placebo - H3 K27M, Glioma | Phase 3 | Recruiting | Jazz Pharmaceuticals | 510 | 2023-01-23 | 2026-04-16 |
Glioma (1)
Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · Denmark (1) · Germany (1) · Hong Kong (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Singapore (1) · South Korea (1) · Spain (1)